Related Experiment Video
Updated: Jun 26, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
UCP1: its involvement and utility in obesity.
1Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA. kozaklp@pbrc.edu
International Journal of Obesity (2005)
|January 13, 2009
Summary
Upregulating the uncoupling protein 1 (UCP1) in brown adipocytes can combat obesity and improve insulin sensitivity. Understanding brown adipocyte origins offers new strategies for enhancing thermogenesis to reduce obesity.
Area of Science:
- Metabolic research
- Obesity research
- Brown adipose tissue biology
Background:
- Energy balance is crucial for preventing obesity, with energy expenditure playing a key role.
- Thermogenesis, mediated by uncoupling protein 1 (UCP1) in brown adipocytes, dissipates energy and protects against hypothermia.
- UCP1 upregulation via genetic or pharmacological means has shown potential in reducing obesity and improving insulin sensitivity.
Purpose of the Study:
- To explore the two distinct sources of brown adipocytes.
- To investigate factors influencing the development and characteristics of these brown adipocyte populations.
- To identify novel strategies for obesity reduction through enhanced thermogenesis.
Main Methods:
- Review of recent evidence on brown adipocyte origins and development.
- Analysis of factors influencing UCP1 expression and thermogenesis.
- Examination of genetic and environmental influences on brown adipocyte populations.
Main Results:
- Two sources of brown adipocytes identified: discrete fetal depots and inducible post-natal populations in white fat depots.
- Inducible brown adipocytes in white fat depots can be stimulated by adrenergic signaling.
- The development of these inducible populations is dependent on genetic background and nutritional environment.
Conclusions:
- Understanding the biological and environmental controls of both brown adipocyte populations is key.
- This knowledge can lead to new therapeutic strategies for obesity by enhancing thermogenesis.
- Targeting UCP1 and brown adipocyte development offers a promising avenue for metabolic disease management.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:37The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...